Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin on Glucagon Counterregulation in Insulin-treated Type 2 Diabetes
NCT01219400Phase 4Completed
- Sponsor
- Lund University
- Start
- Jan 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Lund University. Started Jan 2012; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01219400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01219400.